Rama Kondru
Chief Executive Officer
For nearly 50 years, The Emmes Group has advanced public health through data-driven clinical research. Today, we're applying that same rigor — now powered by AI and purpose-built technology — to enable biopharma and biotech sponsors to run trials faster, smarter, and with fewer surprises.

Who we are
Science Driven
We hold every program to the highest scientific and statistical standards, from protocol design through final analysis.
Patient Focused
Every process improvement and technology investment exists to get safe, effective treatments to patients faster.
Stronger Together
We build long-term partnerships with sponsors, government agencies, and academic institutions to advance research none of us could do alone.

Emmes was founded in 1977 with a focus on biostatistics and public sector research, establishing our foundation as a trusted scientific partner to the U.S. government — including the National Institutes of Health (NIH). Over decades of work with NIH institutes and centers, we helped shape the clinical trial standards and public health practices still used industry-wide today.
That early discipline — scientific precision, regulatory rigor, and data transparency — became the foundation for our expansion into commercial biopharma and global clinical research. The same standards that earned government sponsors' trust now guide every biopharma and biotech program we run.

Emmes Group is built as the industry's first specialty, tech- and AI-based CRO. We're embedding AI and automation into biostatistics, data management, and clinical operations — reducing timelines and manual burden without compromising scientific rigor. For sponsors, that means faster database builds, faster query resolution, and faster answers.

From emerging biotechs to global health agencies, we partner with the organizations working to move science forward.
We support biopharma organizations across the spectrum, from emerging biotech to established global firms, helping move therapies and treatments toward approval and patients.
With a long-standing history supporting U.S. and international government agencies, Emmes Group leads clinical trials, epidemiological studies, and public health research at scale.
We partner with mission-driven organizations that fund and lead high-impact research efforts.
We collaborate with academic centers to advance research through large-scale, multicenter studies.
Emmes Group brings together government, industry, academic, and non-profit stakeholders to accelerate shared research goals.
Learn more about our cloud-based suite of applications for study design, data capture, randomization and reporting.
Request a Meeting
Leadership